These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29355613)

  • 21. Transcriptomic characterization of the histopathological growth patterns in breast cancer liver metastases.
    Leduc S; Nguyen HL; Richard F; Zels G; Mahdami A; De Schepper M; Maetens M; Pabba A; Jaekers J; Latacz E; Bohlok A; Vanderheyden E; Van Brussel T; Boeckx B; Schepers R; Lambrechts D; Dirix L; Larsimont D; Vankerckhove S; Lucidi V; Topal B; Bachir I; Donckier V; Floris G; Vermeulen P; Desmedt C
    Clin Exp Metastasis; 2024 Oct; 41(5):699-705. PubMed ID: 38548918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics.
    Hegde PS; Wallin JJ; Mancao C
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):117-124. PubMed ID: 29229461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histopathological Growth Pattern in Colorectal Liver Metastasis and The Tumor Immune Microenvironment.
    Zaharia C; Veen T; Lea D; Kanani A; Alexeeva M; Søreide K
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphological aspects of the hepatic response to neoadjuvant therapy.
    Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
    Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment.
    Passiglia F; Caglevic C; Giovannetti E; Pinto JA; Manca P; Taverna S; Listì A; Gil-Bazo I; Raez LE; Russo A; Rolfo C
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):259-268. PubMed ID: 29391205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High CIB1 expression in colorectal cancer liver metastases correlates with worse survival and the replacement histopathological growth pattern.
    Fan S; Fleischer JR; Dokshokova L; Böhme LS; Haas G; Schmitt AM; Gätje FB; Rosen LE; Bohnenberger H; Ghadimi M; Cui B; Xu X; Kalucka JM; Bösch F; De Oliveira T; Conradi LC
    Mol Ther Oncol; 2024 Sep; 32(3):200828. PubMed ID: 39072289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of mTOR Signaling in Tumor Microenvironment: An Overview.
    Conciatori F; Bazzichetto C; Falcone I; Pilotto S; Bria E; Cognetti F; Milella M; Ciuffreda L
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia-inducible factors: a central link between inflammation and cancer.
    Triner D; Shah YM
    J Clin Invest; 2016 Oct; 126(10):3689-3698. PubMed ID: 27525434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers for Immunotherapy: Current Developments and Challenges.
    Spencer KR; Wang J; Silk AW; Ganesan S; Kaufman HL; Mehnert JM
    Am Soc Clin Oncol Educ Book; 2016; 35():e493-503. PubMed ID: 27249758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients.
    Bohlok A; Vermeulen P; Leduc S; Latacz E; Botzenhart L; Richard F; De Schepper M; Geukens T; Lucidi V; Ignatiadis M; Aftimos P; Sotiriou C; Piccart M; Hendlisz A; Van Laere S; Dirix L; Noël JC; Biganzoli E; Larsimont D; Desmedt C; Donckier V
    NPJ Breast Cancer; 2020 Dec; 6(1):64. PubMed ID: 33339824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomics and emerging biomarkers for immunotherapy of colorectal cancer.
    Kather JN; Halama N; Jaeger D
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):189-197. PubMed ID: 29501787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy.
    Liu M; Wang H; Liu L; Wang B; Sun G
    J Transl Med; 2016 Jun; 14(1):155. PubMed ID: 27246873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The paradox of Th17 cell functions in tumor immunity.
    Asadzadeh Z; Mohammadi H; Safarzadeh E; Hemmatzadeh M; Mahdian-Shakib A; Jadidi-Niaragh F; Azizi G; Baradaran B
    Cell Immunol; 2017 Dec; 322():15-25. PubMed ID: 29103586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophils: important contributors to tumor progression and metastasis.
    Swierczak A; Mouchemore KA; Hamilton JA; Anderson RL
    Cancer Metastasis Rev; 2015 Dec; 34(4):735-51. PubMed ID: 26361774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokines in cancer.
    Chow MT; Luster AD
    Cancer Immunol Res; 2014 Dec; 2(12):1125-31. PubMed ID: 25480554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer.
    Van den Eynden GG; Van der Auwera I; Van Laere SJ; Colpaert CG; Turley H; Harris AL; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
    Br J Cancer; 2005 Nov; 93(10):1128-36. PubMed ID: 16251878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focused Ultrasound for Immunomodulation of the Tumor Microenvironment.
    Joiner JB; Pylayeva-Gupta Y; Dayton PA
    J Immunol; 2020 Nov; 205(9):2327-2341. PubMed ID: 33077668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Sluiter NR; de Cuba EM; Kwakman R; Meijerink WJ; Delis-van Diemen PM; Coupé VM; Beliën JA; Meijer GA; de Hingh IH; te Velde EA
    Clin Exp Metastasis; 2016 Apr; 33(4):297-307. PubMed ID: 26873137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive tissue biomarkers for bevacizumab-containing therapy in metastatic colorectal cancer: an update.
    Marien KM; Croons V; Martinet W; De Loof H; Ung C; Waelput W; Scherer SJ; Kockx MM; De Meyer GR
    Expert Rev Mol Diagn; 2015 Mar; 15(3):399-414. PubMed ID: 25585649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.